# Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)

> **NCT00623779** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 128 (actual)

## Conditions studied

- Persistent or Permanent Non-valvular Atrial Fibrillation

## Interventions

- **DRUG:** AZD0837
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT00623779
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2012-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00623779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00623779, "Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00623779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*